Project Grant R43HL169121

Award Date 7/1/23
Completion Date 6/30/26
Dollars Obligated $759K
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This $347,386 Project Grant, awarded by the National Science Foundation (NSF) under the Engineering program (CFDA 47.041), aims to develop a novel wearable device for continuous, cuffless blood pressure monitoring. The goal is to create an accurate, inexpensive, and easy-to-use technology to help manage hypertension and reduce hospitalizations associated with this condition. The approach leverages bioimpedance sensing in conjunction with physiological, computational, and machine learning...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $150,000 to the University of Texas at Austin to develop a biomechanics-guided wireless ultrasonic e-tattoo sensor system for continuous, cuffless ambulatory blood pressure monitoring. The key objectives are to: 1) Design an ultra-low-power, millimeter-scale application-specific integrated circuit (ASIC) capable of duplex mode ultrasound...
Dynocardia Inc. received a $256,000 National Science Foundation Project Grant to advance development of a novel continuous, cuffless blood pressure monitoring device. Funded through the NSF Engineering Directorate's SBIR program, the award will support Dynocardia's efforts to address motion artifacts and enable accurate, beat-to-beat blood pressure measurements in hospital intensive care and operating room settings. Accurate 24-hour blood pressure monitoring has potential to significantly...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $237,827 to Brigham & Women's Hospital Inc. to develop a wearable, non-invasive optical device for continuous blood pressure monitoring in neonates. The device, called CNAP-FlexNIRS, will use near-infrared spectroscopy and photoplethysmography to collect high-resolution pulsatile waveforms and...
The National Science Foundation awarded Vena Vitals Inc. a $1 million cooperative agreement under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a wireless, continuous, non-invasive blood pressure monitoring device. The device aims to address the unmet need for real-time blood pressure monitoring of patients undergoing surgery or in critical care by capturing rapid fluctuations with high temporal resolution. Current technologies are limited in accuracy, cost...
This $200,000 Project Grant awarded by the National Science Foundation (NSF) Division of Electrical, Communications and Cyber Systems under CFDA 47.041 (Engineering) aims to develop and implement a novel testing platform to evaluate the accuracy of wearable photoplethysmography-based blood pressure monitoring devices. The University of Maryland, College Park will construct a bench flow phantom that simulates physiologically relevant blood pressure, blood flow, anatomical, and optical...
Ovid BP Systems Inc. received a $713,199 Project Grant award from the National Institutes of Health's National Heart, Lung and Blood Institute on April 15, 2021 to develop a blood pressure monitoring system using video recording on smart cameras. The goal of the Cardiovascular Diseases Research program, CFDA #93.837, is to support heart and vascular research. Under this award, Ovid BP will assess the feasibility of using video-based algorithms to accurately measure blood pressure through...
This $254,369 Project Grant awarded by the National Science Foundation's Engineering program (CFDA 47.041) aims to develop a wearable device capable of continuously sensing physiological signals for use in biometric authentication and health monitoring. The project, titled "Collaborative Research: Novel Robust Continuous Time-Efficient Biometric Profiling and Authentication Using Multispectral Photoplethysmography," will investigate the use of multispectral photoplethysmography (PPG)...
The National Heart, Lung, and Blood Institute (NHLBI) awarded Dynocardia, Inc. a $499,881 Project Grant under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) to complete the verification and validation (V&V) of their production-grade Vitrack hospital device. Vitrack is a wrist-wearable, cuff-less device that utilizes proprietary optomechanical sensor and computer vision technology to provide accurate, continuous, and non-invasive blood pressure monitoring, overcoming...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), is funding the development and testing of a novel wearable device to continuously and accurately measure blood loss for postpartum hemorrhage (PPH) prevention. The $639,165 award, spanning May 2025 to February 2030, supports research at Washington University to design a light-based sensor that can estimate cardiovascular parameters and...

DEVELOPMENT AND VALIDATION OF A WEARABLE ULTRASONIC SENSOR FOR NONINVASIVE BEAT-TO-BEAT BLOOD PRESSURE MONITORING - PROJECT SUMMARY HEMODYNAMIC MONITORING IS OFTEN CARRIED OUT BY INVASIVE TECHNIQUES. NONINVASIVE, CONTINUOUS BLOOD PRESSURE MONITORING IS A MAJOR CHALLENGE IN THE MULTIBILLION-DOLLAR HEALTHCARE INDUSTRY. HOWEVER, THERE IS A CLEAR LACK OF SATISFACTORY NONINVASIVE SOLUTION: BLOOD PRESSURE CUFFS ONLY PROVIDE INTERMITTENT DATA AND CAN BE IRRITATING TO PATIENTS, AND OTHER EMERGING NON-INVASIVE TECHNOLOGIES REQUIRE COMPLEX AND FREQUENT CALIBRATION PROCEDURES AND OFTENTIMES SUFFER FROM PHYSIOLOGICAL OR MEASUREMENT ARTIFACTS. THERE IS A CRITICAL NEED FOR NEW NON-INVASIVE TECHNOLOGIES FOR BLOOD PRESSURE SURVEILLANCE. THE GOAL OF THIS PROJECT IS TO DEVELOP AN EASY-TO-USE NONINVASIVE BLOOD PRESSURE SENSOR PROTOTYPE BASED ON A PROOF-OF-CONCEPT WEARABLE DEVICE DEMONSTRATED BY THE TEAM. THE DEVICE RECORDS THE HUMAN CENTRAL BLOOD PRESSURE WITH A SOFT ULTRASONIC PATCH, WHICH EXTRACTS BLOOD VESSEL DIAMETER BASED ON A-MODE ULTRASOUND RADIOFREQUENCY SIGNALS. THE APPROACH IS ENABLED BY STRETCHABLE ELECTRONIC DESIGNS THAT ALLOW CONFORMAL, SEAMLESS CONTACT OF A SOFT DEVICE WITH THE HUMAN SKIN, ELIMINATING THE NEED FOR COUPLING GEL AT THE DEVICE/SKIN INTERFACE. IN THIS PROJECT, THE CURRENT LAB PROTOTYPE WILL BE REDESIGNED TO ENABLE THE DEVICE APPLICATION IN A CLINICAL SETTING GUIDED BY PHYSICIAN INTERVIEWS. THE MANUFACTURABILITY WILL BE ENHANCED TO PREPARE FOR SCALE-UP. THE APPROACH IS INNOVATIVE BECAUSE IT IS THE FIRST-OF-ITS-KIND TO ACQUIRE THE BLOOD PRESSURE WAVEFORMS OF MAJOR ARTERIES NON-INVASIVELY BY A STRETCHABLE ULTRASONIC PATCH. IN ADDITION, BECAUSE MOST EXISTING DEVICES ON THE MARKET ARE EITHER RIGID OR FLEXIBLE BUT NOT STRETCHABLE, KNOWLEDGE ON STRETCHABLE DEVICE PROTOTYPING AND PACKAGING IS CRITICAL TO TECHNOLOGICAL TRANSLATION OF SIMILAR WEARABLE HEALTH MONITORING SENSORS. THE PROPOSED RESEARCH IS SIGNIFICANT BECAUSE IT AIMS TO USE A BAND-AID-LIKE DEVICE TO COLLECT BEAT-TO-BEAT PRESSURE WAVEFORMS THAT ARE CONVENTIONALLY DONE INVASIVELY. ULTIMATELY, THE PROPOSED APPROACH HAS THE POTENTIAL TO CLEAR THE ROADBLOCK TO PRACTICAL APPLICATIONS FOR CUFFLESS BLOOD PRESSURE SENSING AND IMPACT THE CLINICAL PRACTICE, WHICH CAN EVENTUALLY TRANSLATE TO IMPROVEMENTS IN PATIENT OUTCOMES AND REDUCTIONS IN HEALTHCARE COSTS.

Posted 6/23/23